Results 201 to 210 of about 87,890 (282)

Neonatal Inflammation and Feeding Disorders at 1 Year in Infants With Congenital Gastrointestinal Malformations

open access: yesActa Paediatrica, Volume 114, Issue 7, Page 1702-1708, July 2025.
ABSTRACT Aim To investigate the associations between inflammatory markers and the risk of paediatric feeding disorders (PFD) at 1 year of age in infants with congenital gastrointestinal malformations (CGMs). Methods Neonates with CGMs admitted to our NICU and prospectively followed up in our outpatient clinic were included.
Cristina Mastropietro   +7 more
wiley   +1 more source

Approach to the Management of Gastrointestinal Manifestations in Patients With Phaeochromocytoma and Paraganglioma

open access: yesClinical Endocrinology, Volume 103, Issue 1, Page 21-35, July 2025.
ABSTRACT Objective Managing gastrointestinal symptoms in patients with phaeochromocytoma and paraganglioma (PPGL) is challenging due to the risk of catecholaminergic crisis with many commonly prescribed medications, especially in functional tumours.
Monica Majumder   +5 more
wiley   +1 more source

Total parenteral nutrition in major surgery: role in geriatric age

open access: yesBMC Geriatrics, 2009
Caglià P   +9 more
doaj   +1 more source

Single-staged Anterior versus Posterior Sagittal Anorectoplasty for Low Female Arms.

open access: yesJ Indian Assoc Pediatr Surg
Kheder EME   +4 more
europepmc   +1 more source

Is YouTube™ a useful source of information on home parenteral nutrition? [PDF]

open access: yesBMC Public Health
Wang X   +5 more
europepmc   +1 more source

Pathogenic Deep Intronic PCSK1 Variant Causes Proprotein Convertase 1/3 Deficiency in a Family

open access: yesClinical Genetics, Volume 108, Issue 1, Page 102-106, July 2025.
Biallelic PCSK1 loss‐of‐function mutations cause proprotein convertase 1/3 (PC1/3) deficiency, a polyendocrinopathy; a total of 36 patients were reported. The first deep intronic PCSK1 variant, (NM_000439.5):c.1196+2681T>A, was found to segregate with the disease in a consanguineous family, and is shown together with 32 reported mutations.
Leah M. Huber   +6 more
wiley   +1 more source

Real world evidence of insulin and biosimilar insulin therapy—Opportunities to improve adherence, outcomes and cost‐effectiveness

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue S5, Page 45-62, July 2025.
Abstract Insulin has been discovered for more than a century; however, its benefits to people with diabetes are yet to be fully realized due to barriers related to access, quality of care and costs. Insulin therapy remains the cornerstone of diabetes management. The multicausality of diabetes and its subtypes calls for comprehensive phenotyping and use
Aimin Yang   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy